What is ABT's forecasted revenue?

Abbott Laboratories is forecasted to generate $47.3B in FY revenue, representing +6.7% year-over-year growth.

How accurate is the ABT revenue forecast model?

The ARDL model achieves 3.8% MAPE (Mean Absolute Percentage Error). In a holdout test, it predicted $12B versus the actual $11B.

Abbott Laboratories ABT

Revenue Intelligence Report • 33 quarters of SEC filing data • Updated 2026-03-15

Abbott Laboratories has a forecasted full-year revenue of $47B, a +6.7% year-over-year change, based on 33 quarters of SEC filing data. Key revenue drivers include R&D ($2.76 per $1) and SG&A ($4.33 per $1). The ARDL model achieves strong accuracy at 3.8% MAPE.

Investment Thesis

The econometric model achieves strong accuracy (3.8% MAPE), suggesting Abbott Laboratories's revenue trajectory is well-characterized by its spending patterns. Every $1 of R&D investment is associated with $2.76 of revenue, indicating efficient capital deployment in innovation. Each $1 of SG&A spending generates $4.33 in revenue, reflecting strong commercial efficiency.

Next FY Revenue

$47.3B

+6.7% YoY

R&D Multiplier

$2.76 per $1

SG&A Multiplier

$4.33 per $1

Model Accuracy

3.8% MAPE

Holdout validation: The model predicted $12B vs the actual $11B — an error of 1.2%.

Revenue Forecast

Quarterly Detail

Quarter	Model Forecast	Actual	95% Range	YoY Growth	Status
Q4 2025	$12B	$11B	$11B – $13B	+5.7%	✓ In range
Q2 2026	$12B		$10B – $13B	+12.0%
Q3 2026	$12B		$10B – $13B	+5.0%
Q4 2026	$12B		$10B – $14B	+4.7%
Q1 2027	$12B		$10.0B – $14B	+5.5%

Seasonal Factors

Multiplicative seasonal adjustment: These factors capture Abbott Laboratories's systematic quarterly revenue patterns relative to the trend model. A factor of 1.05 means that quarter typically runs 5% above the underlying trend; 0.95 means 5% below. Factors are computed as the median of (actual / fitted) across all available quarters.

Fiscal Quarter	Seasonal Factor	vs Trend	Interpretation	Obs.
FQ1 (Sep–Nov)	0.9791	-2.1%	In line with trend	7
FQ2 (Dec–Feb)	1.0069	+0.7%	In line with trend	8
FQ3 (Mar–May)	0.9736	-2.6%	In line with trend	7
FQ4 (Jun–Aug)	1.0158	+1.6%	In line with trend	7

How Spending Drives Revenue

Reading this chart: Each line shows the cumulative revenue generated per $1 spent over subsequent quarters. The effect builds over 4-5 quarters as investments mature.

Want this analysis for your portfolio?

I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.

Get in Touch

More in Healthcare

PODD IDXX VTRS PFE REGN COO DHR UNH